EVRA 203 micrograms/24 hours + 33.9 micrograms/24 hours transdermal patch * Pharmacy Only: Prescription
Company:
Gedeon Richter IrelandStatus:
UpdatedLegal Category:
Product subject to medical prescription which may be renewed (B)Active Ingredient(s):
*Additional information is available within the SPC or upon request to the company
Updated on 29 June 2022
File name
62bc7f3a64878.pdf
Reasons for updating
- Change to section 4.3 - Contraindications
- Change to section 4.4 - Special warnings and precautions for use
- Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
- Change to section 4.8 - Undesirable effects
- Change to section 5.2 - Pharmacokinetic properties
- Change to section 10 - Date of revision of the text
Legal category:Product subject to medical prescription which may be renewed (B)
Updated on 29 June 2022
File name
62bc7d6b062a2.pdf
Reasons for updating
- Change to section 2 - what you need to know - contraindications
- Change to section 2 - what you need to know - warnings and precautions
- Change to section 4 - possible side effects
File name
Information sheet for women - IE Gedeon Richter FINAL (3)_1636038976.pdf
Reasons for updating
- Add New Doc
File name
CHC prescriber-checklist - IE Gedeon Richter FINAL (3)_1636038944.pdf
Reasons for updating
- Add New Doc
Updated on 04 November 2021
File name
IE_Evra_203 mcg-24h+33.9mcg-24h_trd_patch_SmPC_1636038534.pdf
Reasons for updating
- New SPC for new product
Legal category:Product subject to medical prescription which may be renewed (B)
Updated on 04 November 2021
File name
IE_Evra_203 mcg-24h+33.9mcg-24h_trd_patch_PIL_1636038503.pdf
Reasons for updating
- New PIL for new product